Bausch Health Companies Inc. Payments of Stock Issuance Costs
Bausch Health Companies Inc. (BHC) had Payments of Stock Issuance Costs of $18.00 million as of 2015-03-27, per its 8-K filed 2018-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2018-08-10
- 2015-03-27: Payments of Stock Issuance Costs $18.00M.
- 2013-06-24: Payments of Stock Issuance Costs $31.00M; Payments of Stock Issuance Costs as first filed $30.50M; Payments of Stock Issuance Costs 0 month $30.70M; Payments of Stock Issuance Costs 0 month as first filed $30.50M.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs as first filed | Payments of Stock Issuance Costs 0 month | Payments of Stock Issuance Costs 0 month as first filed |
|---|---|---|---|---|
| 2015-03-27 | $18.00M 8-K · filed 2018-08-10 | |||
| 2013-06-24 | $31.00M 10-K · filed 2016-04-29 | $30.50M 10-Q · filed 2014-08-01 | $30.70M 10-K · filed 2014-02-28 | $30.50M 10-Q · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |